Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2026)

Krystal Biotech has disclosed Other Operating Expenses across 4 years of filings, most recently posting $6.3 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $6.3 million, up 25.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.3 million (up 147.3% YoY), and the FY2024 annual result was -$37.5 million, down 137.5% from the prior year.
• Other Operating Expenses came in at $6.3 million for Q1 2026 at Krystal Biotech, down from $6.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $100.0 million in Q3 2023 to a low of -$37.5 million in Q4 2024.
• The 4-year median for Other Operating Expenses is $4.6 million (2025), against an average of $6.3 million.
• Across the five-year window, Other Operating Expenses sank 51.93% in 2024 and jumped 137.73% in 2025, its largest moves.
• Krystal Biotech's Other Operating Expenses stood at $100.0 million in 2023, then slumped by 137.5% to -$37.5 million in 2024, then surged by 117.58% to $6.6 million in 2025, then retreated by 4.08% to $6.3 million in 2026.
• The last three Other Operating Expenses figures came in at $6.3 million (Q1 2026), $6.6 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.